Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Vivani Medical, Inc.NASDAQ: VANI
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI falls 23.8% from a year ago
Accumulated OCI stood at $32K at the end of Q1 FY2026, down 23.8% from a year earlier and up 6.7% from the prior quarter. Over 3 fiscal years it compounded at -5.0% a year.
Context
- Accumulated OCI amounted to 0.1% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -23.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 30K USD
- Year-over-year change
- -37.5%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 30K | -37.5% |
| FY2024 | 2024-12-31 | 48K | -65.7% |
| FY2023 | 2023-12-31 | 140K | +300.0% |
| FY2022 | 2022-12-31 | 35K | — |
| FY2021 | 2021-12-31 | 0 | — |
Accumulated OCI vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -23.8% is the 2nd highest of 4, against a peer median of -100.0%.
- Accumulated OCI amounts to 0.1% of total assets for VANI, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$2.83M CAD | — | — | 9.0% | |
| Mar 2026 | $648K USD | +256.9% | — | 1.3% | |
| Mar 2026 | $32K USD | -23.8% | -5.0% | 0.1% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
IMAImageneBio Inc | Mar 2026 | -$17K USD | -117.2% | — | 0.0% |
| Peer median (excluding VANI) | — | -100.0% | — | 0.0% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.